Health minister’s claims about Ottawa’s pharmacare plan deserve a second look

Improving access to pharmaceuticals is a worthy discussion for the coming federal election, but for the public debate to be productive it must be rooted in facts rather than clouded by convenient political rhetoric.

What Health Minister Ginette Petitpas Taylor and the government more broadly misunderstand is the real risk of the provinces and private employers abandoning their existing programs for a federal substitution, which will likely mean skyrocketing costs for the federal government, write Jason Clemens and Bacchus Barua.The Hill Times photograph by Andrew Meade

Opinion

BY BACCHUS BARUA, JASON CLEMENS

July 3, 2019

With the release of Dr. Eric Hoskins’ report on June 12, national pharmacare will likely be a central issue in this fal...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

Top Canadian political and policy opinion and analysis. Saturdays and Sundays. Weekends.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

FOLLOW THE HILL TIMES: